Vanguard Group Inc. Sells 108,397 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Vanguard Group Inc. lowered its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 0.7% during the 4th quarter, Holdings Channel.com reports. The firm owned 14,725,518 shares of the company’s stock after selling 108,397 shares during the quarter. Vanguard Group Inc. owned 0.12% of Henry Schein worth $1,019,006,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in HSIC. Versant Capital Management Inc boosted its position in Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after buying an additional 335 shares during the period. Venturi Wealth Management LLC lifted its stake in shares of Henry Schein by 3,347.1% in the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after acquiring an additional 569 shares during the last quarter. Quent Capital LLC boosted its holdings in Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after acquiring an additional 323 shares during the period. Smartleaf Asset Management LLC grew its position in Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after acquiring an additional 143 shares during the last quarter. Finally, City State Bank purchased a new position in Henry Schein in the 4th quarter worth approximately $55,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Insider Transactions at Henry Schein

In related news, CEO Bradford C. Connett sold 4,036 shares of the company’s stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares in the company, valued at $4,460,251.20. This represents a 6.05 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now owns 24,805 shares of the company’s stock, valued at $1,762,147.20. The trade was a 9.50 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Wall Street Analysts Forecast Growth

HSIC has been the subject of a number of analyst reports. UBS Group dropped their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Wells Fargo & Company began coverage on shares of Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price target for the company. Jefferies Financial Group boosted their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Barrington Research reiterated an “outperform” rating and set a $90.00 target price on shares of Henry Schein in a report on Wednesday, February 26th. Finally, Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and boosted their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $81.10.

Henry Schein Stock Performance

Henry Schein stock opened at $68.62 on Friday. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.49. The stock’s 50 day simple moving average is $74.62 and its two-hundred day simple moving average is $72.60. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The stock has a market cap of $8.52 billion, a price-to-earnings ratio of 28.24, a PEG ratio of 2.13 and a beta of 0.90.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). The firm had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the previous year, the company earned $0.66 earnings per share. As a group, analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.